The Technical AnalystExchange: TLV
Ilex Medical Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.19% ILA6 420.00
America/New_York / 2 mai 2024 @ 10:27
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 718.28 mill |
| EPS: | 4.55 |
| P/E: | 14.11 |
| Earnings Date: | Jan 03, 2025 |
| SharesOutstanding: | 11.19 mill |
| Avg Daily Volume: | 0.0077 mill |
| RATING 2024-05-02 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.02x |
| Company: PE 14.11 | sector: PE 920.02 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.01x |
| Company: PE 14.11 | industry: PE 1 139.76 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
ILA 6 267.11 - 6 572.89 ( +/- 2.38%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | ILA6 420.00 (0.19% ) |
| Volume | 0.0596 mill |
| Avg. Vol. | 0.0077 mill |
| % of Avg. Vol | 772.39 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ILX.TA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ILX.TA
Ilex Medical Ltd engages in marketing, selling, and supporting equipment, disposables, and reagents for laboratories and healthcare establishments in Israel and South Africa. The company offers in vitro diagnostic equipment and reagent systems to hospitals, clinics, and other medical institutions; molecular biology products for cancer screening, retro virus viral load, TB, STDs, and other infectious diseases; and equipment, disposables, and reagents for in vitro fertilization, as well as food and pharma industries. It also distributes and supports nucleic acid testing blood screening solutions to large-scale blood banks; provides pre/post analytics and robotics; and develops, markets, implements, and supports laboratory information systems. In addition, the company offers specialized product range that includes molecular diagnostics, critical care, and immunology products. Ilex Medical Ltd was founded in 1977 and is based in Petah Tikva, Israel.